ProMIS Neurosciences Inc PMN

Share Price vs Market Cap

[DavidKingCanada]

As we all know the SP is very low compared to other Companies with similair Market Caps. I was lucky enough to get in at .08 and have already made my profit. I will be unloading 200K Shares in December if there is no Revenue. 330 Million Shares. We need to so a Reverse Split and Start receiving Revenue. Hoping for a PR this Month. A was pointless for the comming Investor. 

There also seem to be many Members on this Board that do not like PMN and have no faith in the Company. Why post here if you are not Shareholders?

[DavidKingCanada]

*the AGM was pointless to the common Investor.

[goldtech]

Reverse split is devastating to any company without a plan going forward. You DO NOT do a reverse split to record revenues if you had them, first get the revenues.

[DavidKingCanada]

One of the biggest issues with PMN is the Dilution of Shares. 330 Million Shares. 1/3 of those Shares had Voted this past AGM. I believe once the Serology Test is complete there will be Revenue. There is no way the Boston Group and the newly elected Board Members (Respected in their fields) are sitting Idle while Biogens Aducanumab and Eli Lilly's Drug are Approved. If PMN is the Best In Class

[TopBroker]

DavidKing Dont quit your day job. Rollbacks are a sign of a Companies weakness and if revenues are coming then it is better to wait and build the balance sheet . 

[Speyeder999]

Forgive my ignorance on the matter, but with revenue supposedly imminent, can a rollback happen in the foreseeable future (next 6-9months) if the matter wasn't brought up and voted upon at the last AGM?

[DavidKingCanada]

TB you had a Post back in MAY-25-2020 in which you wrote the following speaking on PMN; --- If what my Boston connections tell me are true and I have no doubt, you are about to see this little Biotech skyrocket. --- Soon after you posted that the Stock fell to a all time low at 0.08.  What do your "Boston Connections" tell you for 2021 and 2022? 

[DavidKingCanada]

TB, two days later you wrote the following which is a complete turn around; --- You are correct for the first time, I do not invest in penny stocks and am a deivative specialist. So for you who do not know what that entails, here is an example. Buy 100,000 shares of Merck and sell the September 18, $75.00 calls, net return to investor 11%. Constant returns is where the big money stays. I have one

[TopBroker]

Ridiculous, dont profess to be a stock analyst and tell us what you paid or when you plan to sell, WHO CARES. Your market assessments are quite frankly imateur and your knowledge limited. try doing this day in and day out for a living and see if you survive. Heres one for you, bought the June 400 calls on Biogen at .75 cents and sold the day of the release, now you probably dont even know what

[DavidKingCanada]

TB, you are correct as this is not my Day Job. I manage a Transportation Company and are also involved in the day to day Finances. Every Day Trader bought Calls for Biogen before and after Aducanumab was Approved. Congrats on your $750.00 Profit. And guess what, if you bought Puts instead or Shorted you would have been better off. Anyone can look up the Numbers and see for themselves.I don't